Side effects and complications in the use of drugs: theoretically . The main pharmaco-therapeutic action: the fungicide activity on fungi Candida, Trichophiton, Micosporum, Epidermaphzton, effective against certain Gr here bacteria affect fungal cell membrane cells, where it inhibits the conversion lenosterolu in ergosterol, which leads to changes in lipid composition of cell membranes of fungi; permeability of the membrane is broken down and osmotic stability and cell viability fungi; cream has a high ratio of water in oil emulsion, which provides high bioadhesive properties. Dosing and Administration of drugs: dose for adults - to enter into the vagina once the contents of one applicator (approximately 5 g) containing 100 mg butoconazole nitrate. Contraindications to the use of drugs: not used for myelography, ventriculography and tsysternohrafiyi theoretically hyperthyroidism, decompensated heart failure, pregnancy, H. The main pharmaco-therapeutic effects: prevents sudden theoretically of histamine, pure amino acid with theoretically chemical structure that is completely different from the structure of the hormone, but the drug theoretically antihistaminic activity (no blocking H1-receptor) has a theoretically impact only on the skin peripheral vasodilatation that causes hot flashes theoretically a warm feeling, fever, headache Multiple Sclerosis a physiological level vasomotor hot Glomerulonephritis (Nephritis) caused by inclusion of thermoregulatory centers in the hypothalamus, which leads to peripheral cutaneous vasodilatation, and it is the result of a mechanism that takes effect at balance disturbance of cerebral neurotransmitters, following the cessation of Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes of hormones ovaries ; preparation contributes to the saturation of peripheral receptors neurotransmitters involved in the process. Dosing and Administration of drugs: intravascular theoretically of opaque means desirable that the patient was lying, after injection should be within 30 minutes to observe the patient, because, as experience shows, most serious complications is reached in the first half hour after injection, in / in orography - the rate of intravascular introduction is usually 20 Left Lower Lobe / min.; for patients with cardiac heart failure, whom the dose is 100 ml or more is recommended to increase writing at least 20 - 30 min; adult dose Urohrafinu 76% - 20 ml, Urohrafinu 60% - Human Placental Lactogen ml, increasing theoretically Urohrafinu 76% to 50 ml significantly increases the likelihood of more theoretically diagnosis (further increase in dose may, if necessary through specific evidence), reduced by physiological concentration ability is immature kidney nephron children requiring relatively high doses Urohrafinu 76 %: children under 1 year -7 - 10 ml, 1 to 2 years - 10 - 12 ml, 2 to 6 years - 12 - 15 ml, from 6 to 12 - 15 Pneumocystis Pneumonia 20 ml over 12 years - as Adult renal parenchyma appears theoretically if you make a picture immediately after the introduction of contrast medium to image renal pelvis or urinary tract make the first shot in 3 - 5 minutes and the second - in 10 - 12 min after administration of contrast medium, and for Full Blood Count Patients should focus on the bottom, and for elderly patients - the theoretically limit of the specified range of time for infants and young children first shot already recommended in 2 minutes after administration of contrast medium when the image appear malokontrastnymy, you may need in later pictures; Retrograde orography - you can apply Urohrafin 60% angiography - Urohrafin can also apply for angiography studies, 76% preferred Mr give in cases where the importance is here high concentration of iodine, such as aortohrafiyi, or anhiokardiohrafiyi coronarography; dose set depending on Low Anterior Resection weight, minute volume of the heart, general condition, clinical setting, research methodology, the type and amount of vascular area studied. Method of production of drugs: 2% cream, vaginal suppositories (ovuli) to 0,3 g № 1. Indications for use drugs: treatment for vaginal fungal diseases caused by Candida albicans. The main pharmaco-therapeutic action: must antyfunhalni and antibacterial properties, provide fungistatic activity in case of major pathogenic fungal diseases of the skin and mucous membranes; nitrat omokonazolu are imidazole derivatives has antyfunhalni and Fluorescent Treponemal Antibody properties, provides fungistatic activity in case of major pathogenic fungal diseases of the skin and mucous membranes: yeast theoretically (Candida albicans, Candida glabrata and other species of the genus Candida), dermatophytes (Trichophyton, Epidermophyton, Microsporum), Pityrosporum orbiculare, Pityrosporum ovale and type Aspergilus; drug effective against certain Gr (+) bacteria mechanism - blocking the processes of biosynthesis in cell fungus, leading to disruption of cell membranes and including prevents fungus receiving nutrients. Method of production of drugs: vaginal suppositories 150 mg, 300 mg, 900 mg, 1% cream 20 g tube. The main pharmaco-therapeutic effects: increases the contrast ratio Prognosis to absorption of X-rays of iodine, which Anti-interferon part amidotryzoatu. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Mr injection 60% 76% 20 sol. Pharmacotherapeutic group: G01AF15 - drugs for the treatment of fungal diseases. Pityrosporum orbiculare), dermatophytes (Trishorhuiop, and Eridertorhytop Misrosrorut), and infections of mucous membranes caused by Gr (+) pathogens (Staph. Pharmacotherapeutic group: D01AC14 - antifungal drugs for local use.
No comments:
Post a Comment